References
1
Greenlee WJ.
J. Med. Res. Rev.
1990,
10:
173
2
Huff JR.
J. Med. Chem.
1991,
34:
2305
3
Chun J.
Yin YI.
Yang G.
Tarassishin L.
Li Y.-M.
J. Org. Chem.
2004,
69:
7344
4
Li B.
Buzon RA.
Castaldi MJ.
Org. Process Res. Dev.
2001,
5:
609
5a
Steurer S.
Podlech J.
Eur. J. Org. Chem.
1999,
1551
5b
Steurer S.
Podlech J.
Eur. J. Org. Chem.
2002,
899
6a
Li B.
Buzon RA.
Chiu CK.-F.
Colgan ST.
Jorgensen ML.
Kasthurikrishnan N.
Tetrahedron Lett.
2004,
45:
6887
6b
McWilliams JC.
Armstrong JD.
Zheng N.
Volante BRP.
Reider PJ.
J. Am. Chem. Soc.
1996,
118:
11970
6c
Kano S.
Yokomatsu T.
Shibuya S.
Tetrahedron Lett.
1991,
32:
233
6d
Hormuch S.
Reissig H.-U.
Dorsch D.
Angew. Chem., Int. Ed. Engl.
1993,
32:
1449
7a
Hanazawa T.
Okamoto S.
Sato F.
Org. Lett.
2000,
2:
2369
7b
Hanessian S.
Park H.
Yang R.-Y.
Synlett
1997,
351
8a
Urban FJ.
Jasys VJ.
Org. Process Res. Dev.
2004,
8:
169
8b
Diederich AM.
Ryckman DM.
Tetrahedron Lett.
1993,
34:
6169
9a
Fray AH.
Kaye RL.
Kleinman EF.
J. Org. Chem.
1986,
51:
4828
9b
Nadin A.
Sanchez Lopez JM.
Neduvelil JG.
Thomas SR.
Tetrahedron
2001,
57:
1861
9c
Buhlmayer P.
Caselli A.
Fuhrer W.
Goschke R.
Rasetti V.
Rueger H.
Stanton JL.
Criscione L.
Wood JM.
J. Med. Chem.
1988,
31:
1839
9d
Evans BE.
Rittle KE.
Homnick CF.
Springer JP.
Hirshfield J.
Veber DF.
J. Org. Chem.
1985,
50:
4615
9e
Danielmeier K.
Schierle K.
Steckhan E.
Angew. Chem., Int. Ed. Engl.
1996,
35:
2247
10
Fukuzawa S.-i.
Miura M.
Saitoh T.
J. Org. Chem.
2003,
68:
2042
11a
Dondoni A.
Perrone D.
Semola MT.
J. Org. Chem.
1995,
60:
7927
11b
Dondoni A.
Perrone D.
Tetrahedron Lett.
1992,
33:
7259
12
Ghosh AK.
Mckee SP.
Thompson WJ.
J. Org. Chem.
1991,
56:
6500
13
Sakurai M.
Saito F.
Ohata Y.
Yabe Y.
Nishi T.
Chem. Commun.
1992,
1562
14a
Pasto M.
Moyano A.
Pericas MA.
Riera A.
Tetrahedron Lett.
1998,
39:
1233
14b
Aguilar N.
Moyano A.
Pericas MA.
Riera A.
J. Org. Chem.
1998,
63:
3560
15
Ghosh AK.
Shin D.
Mathivanan P.
Chem. Commun.
1999,
1025
16
Kondekar NB.
Kandula SRV.
Kumar P.
Tetrahedron Lett.
2004,
45:
5477
17
Ghosh AK.
Cappiello J.
Shin D.
Tetrahedron Lett.
1998,
39:
4651
18a
Vabeno J.
Brisander M.
Lejon T.
Luthman K.
J. Org. Chem.
2002,
67:
9186
18b
Chakravarty PK.
de Laszlo SE.
Sarnella CS.
Springer JP.
Schuda PF.
Tetrahedron Lett.
1989,
30:
415
18c
Steuer S.
Podlech J.
Org. Lett.
1999,
1:
481
18d
Brewer M.
Rich DH.
Org. Lett.
2001,
3:
945
18e
Pegorier L.
Larcheveque M.
Tetrahedron Lett.
1995,
36:
2753
18f
Kang SH.
Ryu DH.
Bioorg. Med. Chem. Lett.
1995,
5:
2959
19 Ene-acid 3a is available in multi-kg quantities (Z/E selectivity, 24:1; 83% ee); see ref. 20.
20
Lee KW.
Hwang SY.
Kim CR.
Nam DH.
Chang JH.
Choi BS.
Choi H.-w.
Lee KK.
So B.
Cho SW.
Shin H.
Org. Process Res. Dev.
2003,
7:
839
21
Cooper MS.
Heaney H.
Newbold AJ.
Sanderson WR.
Synlett
1990,
533
22 Preparation of 4a: To a stirred mixture of 3b (660 mg, 1.87 mmol), urea hydrogen peroxide (790 mg, 8.40 mmol), and Na2HPO4 (1.12 g, 7.89 mmol) in CH2Cl2 (10 mL) was added (CF3CO)2O (784 mg, 3.73 mmol) at 0 °C. The mixture was allowed to warm to r.t. and stirred for 4 h. The reaction mixture was washed with a sat. aq solution of NaHCO3, a 5% solution of NaHSO3, and finally H2O. The separated organic layer was concentrated and MTBE (15 mL) was added to the residue. The mixture was stirred for 5 h. The solid formed was filtered and washed with MTBE (2 mL). The cake was dried over a stream of nitrogen to give 4a (615 mg, 86.1%) as a white solid; 4a t
R 31.4 min, ent
-4a t
R 40.8 min (Chiralpak® AD-H; 35 °C; 10% i-PrOH-hexane; 1 mL/min; 250 nm); ee of isolated 4a ³99.9%, while the ee of the filtrate was 50%, which reflects highly selective recrystallization. 1H NMR (CDCl3, 400 MHz): δ = 7.38-7.18 (10 H, m), 5.12 (1 H, d, J = 12.4 Hz), 5.09 (1 H, d, J = 12.4 Hz), 4.95 (1 H, br), 3.71 (1 H, m), 3.67 (3 H, s), 3.32 (1 H, m), 3.07 (1 H, m), 3.01 (1 H, dd, J = 8.0, 4.4 Hz), 2.85 (1 H, dd, J = 13.2, 8.0 Hz), 2.38 (1 H, dd, J = 16.8, 7.6 Hz), 2.03 (1 H, dd, J = 17.2, 4.8 Hz); 13C NMR (CDCl3, 125 MHz): δ = 170.8, 155.8, 136.6, 136.5, 129.6, 128.7, 128.6, 128.2, 128.1, 127.0, 67.0, 57.6, 53.6, 52.0, 51.8, 39.5, 33.3.
23
Ibuka T.
Habashita H.
Otaka A.
Fujii N.
J. Org. Chem.
1991,
56:
4370
24
Brown HC.
Brown CA.
J. Am. Chem. Soc.
1963,
85:
1003
25
Benzyl (1
S
)-1-[(2′
S
)-5′-oxotetrahydrofuran-2′-yl]-2-phenylethylcarbamate (
6): [α]D
25 = -9.6 (CHCl3, c 1); 1H NMR (CDCl3, 500 MHz): δ = 7.34-7.25 (10 H, m), 5.09 (1 H, d, J = 12.4 Hz), 5.05 (1 H, d, J = 12.4 Hz), 4.87 (d, 1 H, J = 10.0Hz), 4.48 (1 H, t, J = 7.8 Hz), 4.07 (dd, 1 H, J = 17.5, 8.7 Hz), 2.98 (1 H, dd, J = 13.3, 6.9 Hz), 2.90 (1 H, dd, J = 13.3, 8.7 Hz), 2.48 (dd, 2 H, J = 9.7, 7.4 Hz), 2.16-2.03 (2 H, m); 13C NMR (CDCl3,125 MHz): δ = 177.2, 156.7, 137.1, 136.4, 129.4, 128.8, 128.6, 128.2, 128.0, 126.9, 79.9, 54.9, 39.3, 28.7, 24.1; MS: m/z = 340 [M + H].
26
Casado-Bellver FJ.
Gonzalez-Rosende ME.
Asensio A.
Jorda-Gregori JM.
Alvarez-Sorolla A.
Sepulveda-Arques J.
Orena M.
Galeazzi R.
J. Chem. Soc., Perkin Trans. 1
2002,
1650
27
Amino-ester side-product (Figure
[1]
): 1H NMR (CDCl3, 400 MHz): δ = 7.34-7.28 (5 H, m), 3.57 (3 H, s), 3.51 (1 H, m), 3.24 (1 H, dd, J = 13.6, 5.6 Hz), 2.95 (1 H, dd, J = 13.6, 8.8 Hz), 2.32 (2 H, m), 1.95-1.69 (4 H, m); MS: m/z = 222 [M + H].
28
Lactam side-product (Figure
[2]
): 1H NMR (CDCl3, 400 MHz): δ = 7.35-7.17 (5 H, m), 5.65 (1 H, br), 3.61 (1 H, m), 2.88 (1 H, dd, J = 13.6, 5.2 Hz), 2.62 (1 H, dd, J = 13.6, 9.2 Hz), 2.43-2.29 (2 H, m), 1.94 (2 H, m), 1.68 (1 H, m), 1.47 (1 H, m); MS: m/z = 190 [M + H] .
29
Benzyl (1
S
)-1-[(2′
R
)-5′-oxotetrahydrofuran-2′-yl]-2-phenylethylcarbamate (
10): [α]D
25 = -8.6 (CHCl3, c 0.02); 1H NMR (CDCl3, 400 MHz): δ = 7.37-7.18 (10 H, m), 5.04 (2 H, s), 4.66 (1 H, br), 4.40 (1 H, m), 4.05 (1 H, m), 3.03 (1 H, dd, J = 14.4, 4.4 Hz), 2.90 (1 H, m), 2.52 (2 H, m), 2.25 (1 H, m), 2.11 (1 H, m); 13C NMR (CDCl3, 100 MHz): δ = 176.6, 165.9, 136.1, 132.7, 129.5, 128.8, 128.6, 128.3, 128.0, 127.0, 80.4, 60.4, 50.0, 30.9, 28.2, 24.7; MS: m/z = 340 [M + H] .